MK-7162

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-7162, covering 2021-11-15 to 2021-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002) [Phase 1]

See pricing